Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Hansa Biopharma and Medison Pharma Announce Positive Reimbursement Decision in Poland for Idefirix® in Highly Sensitized Kidney Transplant Patients
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological […]
£10.4m Full-service Contract Signed With Existing Big Pharma Client
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world […]
Prominent Neurosurgeon Joins Leucadia Therapeutics as Company's Founding Global Chief Medical Officer
Leucadia Therapeutics, a company working to cure Alzheimer’s disease, has hired a global chief medical […]
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head
Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a multi-national company developing innovative therapies […]
Roche Launches COVID-19 Test That Detects and Differentiates the Emerging Variant of Interest BA.2.75
Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a COVID-19 test for […]
James Mock Joins Moderna as Chief Financial Officer
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery
Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced […]
Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy
Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine’s […]
Trial Library Emerges Out of Stealth with $5 Million in Seed Funding, Led by Lux Capital
Trial Library, Inc., an oncology clinical trials company, today announced it has come out of […]
Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care
OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more